Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2

Minghua Li

doi:10.1016/j.chom.2023.08.014

Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2

Minghua Li

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Interferons (IFNs) and interferon-stimulated genes (ISGs) are the major players in the host innate immunity against viral infection. In a recent Nature paper, Xu et al. identified phospholipid scramblase 1 (PLSCR1) as a novel ISG that restricts severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking virus-cell fusion.

Original language	English (US)
Pages (from-to)	1417-1419
Number of pages	3
Journal	Cell Host and Microbe
Volume	31
Issue number	9
DOIs	https://doi.org/10.1016/j.chom.2023.08.014
State	Published - Sep 13 2023

ASJC Scopus subject areas

Parasitology
Microbiology
Virology

Access to Document

10.1016/j.chom.2023.08.014

Cite this

@article{261d64ec80d74a7a9ac86902cd269d5f,

title = "Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2",

abstract = "Interferons (IFNs) and interferon-stimulated genes (ISGs) are the major players in the host innate immunity against viral infection. In a recent Nature paper, Xu et al. identified phospholipid scramblase 1 (PLSCR1) as a novel ISG that restricts severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking virus-cell fusion.",

author = "Minghua Li",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2023",

month = sep,

day = "13",

doi = "10.1016/j.chom.2023.08.014",

language = "English (US)",

volume = "31",

pages = "1417--1419",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "9",

}

TY - JOUR

T1 - Fortifying immunity

T2 - PLSCR1 picks battle against SARS-CoV-2

AU - Li, Minghua

PY - 2023/9/13

Y1 - 2023/9/13

N2 - Interferons (IFNs) and interferon-stimulated genes (ISGs) are the major players in the host innate immunity against viral infection. In a recent Nature paper, Xu et al. identified phospholipid scramblase 1 (PLSCR1) as a novel ISG that restricts severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking virus-cell fusion.

AB - Interferons (IFNs) and interferon-stimulated genes (ISGs) are the major players in the host innate immunity against viral infection. In a recent Nature paper, Xu et al. identified phospholipid scramblase 1 (PLSCR1) as a novel ISG that restricts severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by blocking virus-cell fusion.

UR - https://www.scopus.com/pages/publications/85171350869

UR - https://www.scopus.com/pages/publications/85171350869#tab=citedBy

U2 - 10.1016/j.chom.2023.08.014

DO - 10.1016/j.chom.2023.08.014

M3 - Comment/debate

C2 - 37708846

AN - SCOPUS:85171350869

SN - 1931-3128

VL - 31

SP - 1417

EP - 1419

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 9

ER -

Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this